This company listing is no longer active
Learning 2 Sleep L2S Past Earnings Performance
Past criteria checks 0/6
Learning 2 Sleep L2S's earnings have been declining at an average annual rate of -42.6%, while the Healthcare industry saw earnings growing at 6.5% annually. Revenues have been growing at an average rate of 7.7% per year.
Key information
-42.6%
Earnings growth rate
n/a
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | 7.7% |
| Return on equity | -129.2% |
| Net Margin | -292.4% |
| Last Earnings Update | 30 Jun 2022 |
Recent past performance updates
No updates
Recent updates
No updates
Revenue & Expenses Breakdown
How Learning 2 Sleep L2S makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 22 | 7 | -20 | 0 | 0 |
| 31 Mar 22 | 7 | -18 | 0 | 0 |
| 31 Dec 21 | 7 | -16 | 0 | 0 |
| 31 Dec 20 | 5 | -5 | 0 | 0 |
| 31 Dec 19 | 1 | -5 | 0 | 0 |
| 31 Dec 18 | 0 | -4 | 0 | 0 |
Quality Earnings: HT60 is currently unprofitable.
Growing Profit Margin: HT60 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HT60 is unprofitable, and losses have increased over the past 5 years at a rate of 42.6% per year.
Accelerating Growth: Unable to compare HT60's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HT60 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-23.9%).
Return on Equity
High ROE: HT60 has a negative Return on Equity (-129.21%), as it is currently unprofitable.